In addition, mutations in DNA damage response genes, such as p53 (TP53) and ATM, are found in MDS patients without 5-q deletion [85], and MDS-related U2AF1 mutations lead to alternative splicing in the DNA damage response genes ATR and FANCA [86]. This evidence concerns the gene TP53 and myelodysplastic syndrome.